Skip to main content

Levetiracetam

NDC 64980-606 · Rising Pharma Holdings, Inc.

Generic nameLevetiracetam
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LEVETIRACETAM
Strength750 mg/1
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

64980-606-12 — 120 TABLET, FILM COATED in 1 BOTTLE (64980-606-12)

64980-606-50 — 500 TABLET, FILM COATED in 1 BOTTLE (64980-606-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63187-360 — Levetiracetam, 63323-400 — LEVETIRACETAM, 63629-4137 — Levetiracetam, 63629-4675 — Levetiracetam, 63629-7516 — Levetiracetam, 63629-8315 — Levetiracetam, 63629-9615 — Levetiracetam, 63629-9847 — LEVETIRACETAM, 64980-604 — Levetiracetam, 64980-605 — Levetiracetam, 64980-607 — Levetiracetam, 65145-173 — Levetiracetam in Sodium Chloride, 65145-174 — Levetiracetam in Sodium Chloride, 65145-175 — Levetiracetam in Sodium Chloride, 65162-528 — Levetiracetam, 65162-529 — Levetiracetam, 65162-538 — Levetiracetam, 65162-539 — Levetiracetam, 65162-685 — Levetiracetam, 65219-042 — levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels